参考文献/References:
[1] Powell-Wiley TM,Poirier P,Burke LE,et al. Obesity and cardiovascular disease:a scientific statement from the American Heart Association[J]. Circulation,2021,143(21):e984-e1010.
[2] Gawa?ko M,Saljic A,Li N,et al. Adiposity-associated atrial fibrillation:molecular determinants,mechanisms and clinical significance[J]. Cardiovasc Res,2022 Jun 11:cvac093.
[3] Yamaguchi Y,Cavallero S,Patterson M,et al. Adipogenesis and epicardial adipose tissue:a novel fate of the epicardium induced by mesenchymal transformation and PPARγ activation[J]. Proc Natl Acad Sci U S A,2015,112(7):2070-2075.
[4] Ernault AC,Meijborg VMF,Coronel R. Modulation of cardiac arrhythmogenesis by epicardial adipose tissue:JACC state-of-the-art review[J]. J Am Coll Cardiol,2021,78(17):1730-1745.
[5] Nalliah CJ,Bell JR,Raaijmakers AJA,et al. Epicardial adipose tissue accumulation confers atrial conduction abnormality[J]. J Am Coll Cardiol,2020,76(10):1197-1211.
[6] Zhu J,Yang Z,Chen X,et al. A stronger association of epicardial fat volume with non-valvular atrial fibrillation than measures of general obesity in Chinese patients undergoing computed tomography coronary angiography[J]. Diabetes Metab Syndr Obes,2021,14:1223-1232.
[7] Nakanishi K,Fukuda S,Tanaka A,et al. Peri-atrial epicardial adipose tissue is associated with new-onset nonvalvular atrial fibrillation[J]. Circ J,2012,76(12):2748-2754.
[8] Chen J,Mei Z,Yang Y,et al. Epicardial adipose tissue is associated with higher recurrence risk after catheter ablation in atrial fibrillation patients:a systematic review and meta-analysis[J]. BMC Cardiovasc Disord,2022,22(1):264.
[9] Ciuffo L,Nguyen H,Marques MD,et al. Periatrial fat quality predicts atrial fibrillation ablation outcome[J]. Circ Cardiovasc Imaging,2019,12(6):e008764.
[10] Dereli S,Bayramo?lu A,Yontar OC,et al. Epicardial fat thickness:a new predictor of successful electrical cardioversion and atrial fibrillation recurrence[J]. Echocardiography,2018,35(12):1926-1931.
[11] Pabon MA,Manocha K,Cheung JW,et al. Linking arrhythmias and adipocytes:insights,mechanisms,and future directions[J]. Front Physiol,2018,9:1752.
[12] Rix TA,Dinesen P,Lundbye-Christensen S,et al. Omega-3 fatty acids in adipose tissue and risk of atrial fibrillation[J]. Eur J Clin Invest,2022,52(1):e13649.
[13] Kornej J,Lin H,Trinquart L,et al. Neck circumference and risk of incident atrial fibrillation in the Framingham Heart Study[J]. J Am Heart Assoc,2022,11(4):e022340.
[14] Yu L,Wang Y,Zhou X,et al. Leptin injection into the left stellate ganglion augments ischemia-related ventricular arrhythmias via sympathetic nerve activation[J]. Heart Rhythm,2018,15(4):597-606.
[15] Zhou Z,Li S,Sheng X,et al. Interactions between metabolism regulator adiponectin and intrinsic cardiac autonomic nervous system:a potential treatment target for atrial fibrillation[J]. Int J Cardiol,2020,302:59-66.
[16] Dobrev D,Heijman J,Hiram R,et al. Inflammatory signalling in atrial cardiomyocytes:a novel unifying principle in atrial fibrillation pathophysiology[J]. Nat Rev Cardiol,2022 Sep 15:1-23.
[17] Couselo-Seijas M,Rodríguez-Ma?ero M,González-Juanatey JR,et al. Updates on epicardial adipose tissue mechanisms on atrial fibrillation[J]. Obes Rev,2021,22(9):e13277.
[18] Wang Q,Shen H,Min J,et al. YKL-40 is highly expressed in the epicardial adipose tissue of patients with atrial fibrillation and associated with atrial fibrosis[J]. J Transl Med,2018,16(1):229.
[19] Kourliouros A,Karastergiou K,Nowell J,et al. Protective effect of epicardial adiponectin on atrial fibrillation following cardiac surgery[J]. Eur J Cardiothorac Surg,2011,39(2):228-232.
[20] Samanta R,Pouliopoulos J,Thiagalingam A,et al. Role of adipose tissue in the pathogenesis of cardiac arrhythmias[J]. Heart Rhythm,2016,13(1):311-320.
[21] Jian B,Li Z,Wang J,et al. Correlation analysis between heart rate variability,epicardial fat thickness,visfatin and AF recurrence post radiofrequency ablation[J]. BMC Cardiovasc Disord,2022,22(1):65.
[22] Abe I,Teshima Y,Kondo H,et al. Association of fibrotic remodeling and cytokines/chemokines content in epicardial adipose tissue with atrial myocardial fibrosis in patients with atrial fibrillation[J]. Heart Rhythm,2018,15(11):1717-1727.
[23] Abed HS,Samuel CS,Lau DH,et al. Obesity results in progressive atrial structural and electrical remodeling:implications for atrial fibrillation[J]. Heart Rhythm,2013,10(1):90-100.
[24] Fox CS,Gona P,H offmann U,et al. Pericardial fat,intrathoracic fat,and measures of left ventricular structure and function:the Framingham Heart Study[J]. Circulation,2009,119(12):1586-1591.
[25] Mancio J,Azevedo D,Fragao-Marques M,et al. Meta-analysis of relation of epicardial adipose tissue volume to left atrial dilation and to left ventricular hypertrophy and functions[J]. Am J Cardiol,2019,123(3):523-531.
[26] Mancio J,Sousa-Nunes F,Martins R,et al. Decoding the radiomic and proteomic phenotype of epicardial adipose tissue associated with adverse left atrial remodelling and post-operative atrial fibrillation in aortic stenosis[J]. Eur Heart J Cardiovasc Imaging,2022,23(9):1248-1259.
[27] Ardissino M,McCracken C,Bard A,et al. Pericardial adiposity is independently linked to adverse cardiovascular phenotypes:a CMR study of 42 598 UK Biobank participants[J]. Eur Heart J Cardiovasc Imaging,2022,23(11):1471-1481.
[28] Shaihov-Teper O,Ram E,Ballan N,et al. Extracellular vesicles from epicardial fat facilitate atrial fibrillation[J]. Circulation,2021,143(25):2475-2493.
[29] Ernault AC,Verkerk AO,Bayer JD,et al. Secretome of atrial epicardial adipose tissue facilitates reentrant arrhythmias by myocardial remodeling[J]. Heart Rhythm,2022,19(9):1461-1470.
[30] Viviano A,Yin X,Zampetaki A,et al. Proteomics of the epicardial fat secretome and its role in post-operative atrial fibrillation[J]. Europace,2018,20(7):1201-1208.
[31] Zhao L,Ma Z,Guo Z,et al. Analysis of long non-coding RNA and mRNA profiles in epicardial adipose tissue of patients with atrial fibrillation[J]. Biomed Pharmacother,2020,121:109634.
[32] Katritsis DG,Pokushalov E,Romanov A,et al. Autonomic denervation added to pulmonary vein isolation for paroxysmal atrial fibrillation:a randomized clinical trial[J]. J Am Coll Cardiol,2013,62(24):2318-2325.
[33] Garabelli P,Stavrakis S,Kenney JFA,et al. Effect of 28-mm cryoballoon ablation on major atrial ganglionated plexi[J]. JACC Clin Electrophysiol,2018,4(6):831-838.
[34] Li B,Po SS,Zhang B,et al. Metformin regulates adiponectin signalling in epicardial adipose tissue and reduces atrial fibrillation vulnerability[J]. J Cell Mol Med,2020,24(14):7751-7766.
[35] Soucek F,Covassin N,Singh P,et al. Effects of atorvastatin(80 mg) therapy on quantity of epicardial adipose tissue in patients undergoing pulmonary vein isolation for atrial fibrillation[J]. Am J Cardiol,2015,116(9):1443-1446.
[36] Mahajan R,Lau DH,Brooks AG,et al. Atrial fibrillation and obesity:reverse remodeling of atrial substrate with weight reduction[J]. JACC Clin Electrophysiol,2021,7(5):630-641.
[37] Conte M,Petraglia L,Cabaro S,et al. Epicardial adipose tissue and cardiac arrhythmias:focus on atrial fibrillation[J]. Front Cardiovasc Med,2022,9:932262.
[38] Colonetti T,Grande AJ,Amaral MC,et al. Effect of exercise on epicardial adipose tissue in adults:a systematic review and meta-analyses[J]. Heart Fail Rev,2021,26(6):1399-1411.
[39] Saco-Ledo G,Valenzuela PL,Castillo-García A,et al. Physical exercise and epicardial adipose tissue:a systematic review and meta-analysis of randomized controlled trials[J]. Obes Rev,2021,22(1):e13103.
[40] Yu L,Scherlag BJ,Dormer K,et al. Autonomic denervation with magnetic nanoparticles[J]. Circulation,2010,122(25):2653-2659.
[41] Yu L,Scherlag BS,Dormer K,et al. Targeted ganglionated plexi denervation using magnetic nanoparticles carrying calcium chloride payload[J]. JACC Clin Electrophysiol,2018,4(10):1347-1358.
[42] Wang H,Zhang Y,Xin F,et al. Calcium-induced autonomic denervation in patients with post-operative atrial fibrillation[J]. J Am Coll Cardiol,2021,77(1):57-67.
[43] Lo LW,Chang HY,Scherlag BJ,et al. Temporary suppression of cardiac ganglionated plexi leads to long-term suppression of atrial fibrillation:evidence of early autonomic intervention to break the vicious cycle of “AF begets AF”[J]. J Am Heart Assoc,2016,5(7):e003309.
[44] Zhang S,Wang M,Jiao L,et al. Ultrasound-guided injection of botulinum toxin type A blocks cardiac sympathetic ganglion to improve cardiac remodeling in a large animal model of chronic myocardial infarction[J]. Heart Rhythm,2022,19(12):2095-2104.
[45] Couselo-Seijas M,López-Canoa JN,Agra-Bermejo RM,et al. Cholinergic activity regulates the secretome of epicardial adipose tissue:association with atrial fibrillation[J]. J Cell Physiol,2019,234(7):10512-10522.
[46] Romanov A,Pokushalov E,Ponomarev D,et al. Long-term suppression of atrial fibrillation by botulinum toxin injection into epicardial fat pads in patients undergoing cardiac surgery:three-year follow-up of a randomized study[J]. Heart Rhythm,2019,16(2):172-177.
相似文献/References:
[1]贺鹏康,周菁.心房颤动治疗新技术——冷冻球囊消融[J].心血管病学进展,2016,(1):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
HE Pengkang,ZHOU Jing.Cryoballoon Ablation, A Novel Technology for Atrial Fibrillation Treatment[J].Advances in Cardiovascular Diseases,2016,(3):1.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.001]
[2]都明辉,施海峰*,佟佳宾,等.心房颤动消融相关性无症状性脑缺血[J].心血管病学进展,2016,(1):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
DU Minghui,SHI Haifeng*,TONG Jiabin,et al.Silent Cerebral Ischemia Related to Atrial Fibrillation Ablation[J].Advances in Cardiovascular Diseases,2016,(3):3.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.002]
[3]郑环杰,综述,肖骅,等.心房颤动抗栓治疗研究进展[J].心血管病学进展,2016,(2):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
ZHENG Huanjie,XIAO Hua.Progress of Antithrombotic Therapy in Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(3):142.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.012]
[4]张清,综述,罗素新,等.新型Xa 因子抑制剂———依度沙班在心房颤动患者抗凝治疗中的研究进展[J].心血管病学进展,2016,(2):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
ZHANG Qing,LUO Suxin,TANG Jiong.Novel Factor Xa Inhibitors—Edoxaban in Prevention of Stroke in
Patients with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(3):151.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.014]
[5]胡红玲,综述,罗素新,等.预防非瓣膜性心房颤动性脑卒中的治疗新进展[J].心血管病学进展,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
HU Hongling,LUO Suxin.New Progress in the Treatment for Cerebral Apoplexy of Nonvalvular
Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(3):250.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.009]
[6]王超,杨国澍,综述,等.关附甲素治疗心房颤动的研究进展[J].心血管病学进展,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
WANG Chao,YANG Guoshu,CAI Lin,et al.Research Progress of the Treatment of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(3):254.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.010]
[7]徐小东,综述,杨东辉,等.决奈达隆治疗心房颤动的现状及展望[J].心血管病学进展,2016,(4):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
XU Xiaodong,YANG Donghui.Status and Prospect of Dronedarone in Treating Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2016,(3):368.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.011]
[8]张莎,储国俊,吴弘.经导管左心耳封堵术的临床应用进展[J].心血管病学进展,2015,(5):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
ZHANG Sha,CHU Guojun,WU Hong.Clinial Application Advances in Left Atrial Appendage Closure[J].Advances in Cardiovascular Diseases,2015,(3):547.[doi:10.3969/j.issn.1004-3934.2015.05.006]
[9]汪俊,杨浩.心房颤动射频消融的术式演变[J].心血管病学进展,2015,(5):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
WANG Jun,YANG Hao.Evolution of Radiofrequency Ablation of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2015,(3):574.[doi:10.3969/j.issn.1004-3934.2015.05.013]
[10]赵璐,苏立.心房颤动与离子通道重构研究进展[J].心血管病学进展,2015,(5):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]
ZHAO Lu,SU Li.Research Progress of Atrial Fibrillation and Ion Channel Remodeling[J].Advances in Cardiovascular Diseases,2015,(3):580.[doi:10.3969/j.issn.1004-3934.2015.05.014]